原知明

ハラトモアキ | Hara Tomoaki

所属機関・部署：
職名：特任助教
競争的資金等の研究課題 (6件)：

全件表示

論文 (18件)：

Tomoaki Hara, Sikun Meng, Daisuke Motooka, Hiromichi Sato, Yasuko Arao, Yoshiko Tsuji, Takeshi Yabumoto, Yuichiro Doki, Hidetoshi Eguchi, Shizuka Uchida, et al. Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease. Cancer science. 2024
Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Kazuki Sasaki, Yu Takeda, Yoshiko Tsuji, Yasuko Arao, Ken Ofusa, Toru Kitagawa, et al. High N6-methyladenosine-activated TCEAL8 mRNA is a novel pancreatic cancer marker. Cancer science. 2024
Tomoaki Hara, Sikun Meng, Yoshiko Tsuji, Yasuko Arao, Yoshiko Saito, Hiromichi Sato, Daisuke Motooka, Shizuka Uchida, Hideshi Ishii. RN7SL1 may be translated under oncogenic conditions. Proceedings of the National Academy of Sciences of the United States of America. 2024. 121. 12. e2312322121
Sikun Meng, Tomoaki Hara, Hiromichi Sato, Shotaro Tatekawa, Yoshiko Tsuji, Yoshiko Saito, Yumiko Hamano, Yasuko Arao, Noriko Gotoh, Kazuhiko Ogawa, et al. Revealing neuropilin expression patterns in pancreatic cancer: From single-cell to therapeutic opportunities (Review). Oncology letters. 2024. 27. 3. 113-113
Yuki Ozato, Tomoaki Hara, Sikun Meng, Hiromichi Sato, Shotaro Tatekawa, Mamoru Uemura, Takeshi Yabumoto, Shizuka Uchida, Kazuhiko Ogawa, Yuichiro Doki, et al. RNA methylation in inflammatory bowel disease. Cancer Science. 2024

学歴 (3件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

原 知明